Evidence map›Paper›PMID 26414661›Full record

ArticlePloS one2015

High Fat Diet Enhances β-Site Cleavage of Amyloid Precursor Protein (APP) via Promoting β-Site APP Cleaving Enzyme 1/Adaptor Protein 2/Clathrin Complex Formation.

Masato Maesako, Maiko Uemura, Yoshitaka Tashiro, Kazuki Sasaki, Kiwamu Watanabe, Yasuha Noda, Karin Ueda, Megumi Asada-Utsugi, Masakazu Kubota, Katsuya Okawa and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.International review of cell and molecular biology · 2018
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Masato MaesakoDepartment of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Maiko UemuraDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Yoshitaka TashiroSK project Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kazuki SasakiDepartment of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kiwamu WatanabeDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Yasuha NodaDepartment of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Karin UedaDepartment of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Megumi Asada-UtsugiDepartment of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Masakazu KubotaDepartment of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Katsuya OkawaKyowa Hakko Kirin Co., Ltd, Shizuoka, Japan.
Masafumi IharaDepartment of Neurology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Shun ShimohamaDepartment of Neurology, Sapporo Medical University, Sapporo, Japan.
Kengo UemuraDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Ishiki Hospital, Kagoshima, Japan.
Ayae KinoshitaDepartment of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kyoto University · JPKyowa Kirin (Japan) · JPNational Cerebral and Cardiovascular Center · JPSapporo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity and type 2 diabetes are risk factors of Alzheimer's disease (AD). We reported that a high fat diet (HFD) promotes amyloid precursor protein (APP) cleavage by β-site APP cleaving enzyme 1 (BACE1) without increasing BACE1 levels in APP transgenic mice. However, the detailed mechanism had remained unclear. Here we demonstrate that HFD promotes BACE1/Adaptor protein-2 (AP-2)/clathrin complex formation by increasing AP-2 levels in APP transgenic mice. In Swedish APP overexpressing Chinese hamster ovary (CHO) cells as well as in SH-SY5Y cells, overexpression of AP-2 promoted the formation of BACE1/AP-2/clathrin complex, increasing the level of the soluble form of APP β (sAPPβ). On the other hand, mutant D495R BACE1, which inhibits formation of this trimeric complex, was shown to decrease the level of sAPPβ. Overexpression of AP-2 promoted the internalization of BACE1 from the cell surface, thus reducing the cell surface BACE1 level. As such, we concluded that HFD may induce the formation of the BACE1/AP-2/clathrin complex, which is followed by its transport of BACE1 from the cell surface to the intracellular compartments. These events might be associated with the enhancement of β-site cleavage of APP in APP transgenic mice. Here we present evidence that HFD, by regulation of subcellular trafficking of BACE1, promotes APP cleavage.

Indexed as

Adaptor Protein Complex 2Alzheimer DiseaseAmino Acid SubstitutionAmyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesAnimalsAspartic Acid EndopeptidasesCHO CellsCricetinaeCricetulusDietary FatsHumansMiceMice, TransgenicMutation, MissenseObesityAdaptor Protein Complex 2Amyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesAPP protein, humanAspartic Acid EndopeptidasesBace1 protein, mouseDietary Fats

Identifiers

PMID26414661
PMCPMC4587376
OpenAlexW2232674046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.